A large subgroup of mild-to-moderate asthma is persistently noneosinophilic.

Abstract

Approximately half of patients with mild-to-moderate asthma have persistently noneosinophilic disease, a disease phenotype that responds poorly to currently available antiinflammatory therapy.

Full Text

DOI - American journal of respiratory and critical care medicine (DOI)
ProQuest Information and Learning - full-text online
HighWire Press - full-text online

Subjects

Similar articles

Where asthma and hypersensitivity pneumonitis meet and differ: noneosinophilic severe asthma. (2009-01-02)
Airway inflammation assessed by invasive and noninvasive means in severe asthma: eosinophilic and noneosinophilic phenotypes. (2006-11-07)
Eosinophil protein in airway macrophages: a novel biomarker of eosinophilic inflammation in patients with asthma. (2010-07-16)
Clinical characteristics of eosinophilic and noneosinophilic asthma in children. (2012-11-01)
Cluster analysis and clinical asthma phenotypes. (2008-07-24)
Determining asthma treatment by monitoring sputum cell counts: effect on exacerbations. (2006-03-01)
Corticosteroids: still at the frontline in asthma treatment? (2012-07-12)
Airway remodeling-associated mediators in moderate to severe asthma: effect of steroids on TGF-beta, IL-11, IL-17, and type I and type III collagen expression. (2003-06-05)
Noneosinophilic asthma in children: relation with airway remodelling. (2011-09-02)

Authors

Publication date

2012-03-16

Journal

American journal of respiratory and critical care medicine
Am J Respir Crit Care Med (1535-4970)

Journal topics

Language

Eng.

Copyright

American journal of respiratory and critical care medicine

Cardiovascular Research Institute, University of California San Francisco, San Francisco, CA 94143, USA.

Release reference

Am J Respir Crit Care Med. 2012 Mar;185(6):612-9

Related books

Español | English

© Galenicom 1999-2013